Abstract
The lung must maintain a high threshold of immune 'ignorance' to innocuous antigens to avoid inflammatory disease that depends on the balance of positive inflammatory signals and repressor pathways. We demonstrate here that airway macrophages had higher expression of the negative regulator CD200 receptor (CD200R) than did their systemic counterparts. Lung macrophages were restrained by CD200 expressed on airway epithelium. Mice lacking CD200 had more macrophage activity and enhanced sensitivity to influenza infection, which led to delayed resolution of inflammation and, ultimately, death. The administration of agonists that bind CD200R, however, prevented inflammatory lung disease. Thus, CD200R is critical for lung macrophage immune homeostasis in the resting state and limits inflammatory amplitude and duration during pulmonary influenza infection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Raz, E. Organ-specific regulation of innate immunity. Nat. Immunol. 8, 3–4 (2007).
Matzinger, P. Friendly and dangerous signals: is the tissue in control? Nat. Immunol. 8, 11–13 (2007).
Bingisser, R.M. & Holt, P.G. Immunomodulating mechanisms in the lower respiratory tract: nitric oxide mediated interactions between alveolar macrophages, epithelial cells, and T-cells. Swiss Med. Wkly. 131, 171–179 (2001).
Munger, J.S. et al. The integrin αVβ6 binds and activates latent TGF-β1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319–328 (1999).
Takabayshi, K. et al. Induction of a homeostatic circuit in lung tissue by microbial compounds. Immunity 24, 475–487 (2006).
Morris, D.G. et al. Loss of integrin αVβ6-mediated TGF-β activation causes Mmp12-dependent emphysema. Nature 422, 169–173 (2003).
Wright, G.J. et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13, 233–242 (2000).
Wright, G.J. et al. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J. Immunol. 171, 3034–3046 (2003).
Zhang, S., Cherwinski, H., Sedgwick, J.D. & Phillips, J.H. Molecular mechanisms of CD200 inhibition of mast cell activation. J. Immunol. 173, 6786–6793 (2004).
Cherwinski, H.M. et al. The CD200 receptor is a novel and potent regulator of murine and human mast cell function. J. Immunol. 174, 1348–1356 (2005).
Shiratori, I. et al. Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. J. Immunol. 175, 4441–4449 (2005).
Barclay, A.N. & Ward, H.A. Purification and chemical characterisation of membrane glycoproteins from rat thymocytes and brain, recognised by monoclonal antibody MRC OX 2. Eur. J. Biochem. 129, 447–458 (1982).
Hoek, R.M. et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290, 1768–1771 (2000).
Wright, G.J., Jones, M., Puklavec, M.J., Brown, M.H. & Barclay, A.N. The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology 102, 173–179 (2001).
Webb, M. & Barclay, A.N. Localisation of the MRC OX-2 glycoprotein on the surfaces of neurones. J. Neurochem. 43, 1061–1067 (1984).
Dick, A.D., Broderick, C., Forrester, J.V. & Wright, G.J. Distribution of OX2 antigen and OX2 receptor within retina. Invest. Ophthalmol. Vis. Sci. 42, 170–176 (2001).
Bukovsky, A., Presl, J. & Zidovsky, J. Association of some cell surface antigens of lymphoid cells and cell surface differentiation antigens with early rat pregnancy. Immunology 52, 631–640 (1984).
Nathan, C. & Muller, W.A. Putting the brakes on innate immunity: a regulatory role for CD200? Nat. Immunol. 2, 17–19 (2001).
Chen, Z., Zeng, H. & Gorczynski, R.M. Cloning and characterization of the murine homologue of the rat/human MRC OX-2 gene. Biochim. Biophys. Acta 1362, 6–10 (1997).
McCaughan, G.W., Clark, M.J. & Barclay, A.N. Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein. Immunogenetics 25, 329–335 (1987).
de Heer, H.J., Hammad, H., Kool, M. & Lambrecht, B.N. Dendritic cell subsets and immune regulation in the lung. Semin. Immunol. 17, 295–303 (2005).
Fernandez, S., Jose, P., Avdiushko, M.G., Kaplan, A.M. & Cohen, D.A. Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists. J. Immunol. 172, 2613–2620 (2004).
Tuthill, T.J. et al. Mouse respiratory epithelial cells support efficient replication of human rhinovirus. J. Gen. Virol. 84, 2829–2836 (2003).
Gardai, S.J. et al. By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115, 13–23 (2003).
Mestecky, J., Russell, M.W. & Elson, C.O. Perspectives on mucosal vaccines: is mucosal tolerance a barrier? J. Immunol. 179, 5633–5638 (2007).
Kong, X.N. et al. LPS-induced down-regulation of signal regulatory protein α contributes to innate immune activation in macrophages. J. Exp. Med. 204, 2719–2731 (2007).
Liew, F.Y., Xu, D., Brint, E.K. & O'Neill, L.A. Negative regulation of Toll-like receptor–mediated immune responses. Nat. Rev. Immunol. 5, 446–458 (2005).
Han, J. & Ulevitch, R.J. Limiting inflammatory responses during activation of innate immunity. Nat. Immunol. 6, 1198–1205 (2005).
Carmody, R.J., Ruan, Q., Palmer, S., Hilliard, B. & Chen, Y.H. Negative regulation of Toll-like receptor signaling by NF-κB p50 ubiquitination blockade. Science 317, 675–678 (2007).
Broderick, C. et al. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am. J. Pathol. 161, 1669–1677 (2002).
Taylor, N. et al. Enhanced tolerance to autoimmune uveitis in CD200–deficient mice correlates with a pronounced Th2 switch in response to antigen challenge. J. Immunol. 174, 143–154 (2005).
Copland, D.A. et al. Monoclonal antibody–mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am. J. Pathol. 171, 580–588 (2007).
Banerjee, D. & Dick, A.D. Blocking CD200–CD200 receptor axis augments NOS-2 expression and aggravates experimental autoimmune uveoretinitis in Lewis rats. Ocul. Immunol. Inflamm. 12, 115–125 (2004).
Karupiah, G., Chen, J.H., Mahalingam, S., Nathan, C.F. & MacMicking, J.D. Rapid interferon γ-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J. Exp. Med. 188, 1541–1546 (1998).
Akaike, T. Role of free radicals in viral pathogenesis and mutation. Rev. Med. Virol. 11, 87–101 (2001).
Akaike, T. et al. Pathogenesis of influenza virus–induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 93, 2448–2453 (1996).
Snelgrove, R.J., Edwards, L., Rae, A.J. & Hussell, T. An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur. J. Immunol. 36, 1364–1373 (2006).
Hussell, T., Pennycook, A. & Openshaw, P.J. Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur. J. Immunol. 31, 2566–2573 (2001).
Peper, R.L. & Van Campen, H. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb. Pathog. 19, 175–183 (1995).
Cook, D.N. et al. Requirement of MIP-1 α for an inflammatory response to viral infection. Science 269, 1583–1585 (1995).
Snelgrove, R.J., Edwards, L., Williams, A.E., Rae, A.J. & Hussell, T. In the absence of reactive oxygen species, T cells default to a Th1 phenotype and mediate protection against pulmonary Cryptococcus neoformans infection. J. Immunol. 177, 5509–5516 (2006).
Lawrence, T., Gilroy, D.W., Colville-Nash, P.R. & Willoughby, D.A. Possible new role for NF-κB in the resolution of inflammation. Nat. Med. 7, 1291–1297 (2001).
Barclay, A.N., Wright, G.J., Brooke, G. & Brown, M.H. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 23, 285–290 (2002).
Dong, K.K. et al. Adaptive immune cells temper initial innate responses. Nat. Med. 13, 1248–1252 (2007).
Rosenblum, M.D. et al. CD200 is a novel p53-target gene involved in apoptosis–associated immune tolerance. Blood 103, 2691–2698 (2004).
Gorczynski, R.M., Chen, Z., Yu, K. & Hu, J. CD200 immunoadhesin suppresses collagen-induced arthritis in mice. Clin. Immunol. 101, 328–334 (2001).
Gorczynski, R.M., Chen, Z., Lee, L., Yu, K. & Hu, J. Anti–CD200R ameliorates collagen-induced arthritis in mice. Clin. Immunol. 104, 256–264 (2002).
Gorczynski, R.M. et al. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. J. Immunol. 163, 1654–1660 (1999).
Lipatov, A.S. et al. Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. J. Gen. Virol. 86, 1121–1130 (2005).
Chan, M.C. et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 6, 135 (2005).
de Jong, M.D. et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203–1207 (2006).
Peiris, J.S. et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363, 617–619 (2004).
Boudakov, I. et al. Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factor-α and mixed leukocyte culture responses by CD200. Transplantation 84, 251–257 (2007).
Arase, H., Arase, N., Nakagawa, K., Good, R.A. & Onoe, K. NK1.1+ CD4+ CD8− thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23, 307–310 (1993).
Hussell, T., Spender, L.C., Georgiou, A., O'Garra, A. & Openshaw, P.J.M. Th1 and Th2 cytokine induction in pulmonary T-cells during infection with respiratory syncytial virus. J. Gen. Virol. 77, 2447–2455 (1996).
Corti, M., Brody, A.R. & Harrison, J.H. Isolation and primary culture of murine alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 14, 309–315 (1996).
Acknowledgements
Influenza X31 virus was a gift from A. Douglas (National Institute for Medical Research, London); rat agonistic anti-mouse CD200R IgG1 was donated by N. Barclay (Oxford); and LA-4 cells were a gift from S. Johnston (Imperial College, London). Supported by the Medical Research Council (P171/03/C1/048), the US National Institutes of Health (NGA:1 U01 AI070232–01), the Wellcome Trust (082727/Z/07/Z) and the European Union (032296).
Author information
Authors and Affiliations
Contributions
T.H. and R.J.S. planned, executed and interpreted the experiments and prepared the manuscript; J.G. did many experiments and finalized the figures for publication; A.M.D. assisted with the purification of airway epithelial cells and alveolar macrophages; D.L., S.V., L.E. and E.G. provided technical contributions to the paper; and J.D.S. and A.N.B. provided key reagents and contributed discussions throughout the work.
Corresponding author
Ethics declarations
Competing interests
T.H. has stock in and is assisting StormBio to develop an H5N1 mouse model to be used for testing cytokine blockade; CD200 may be considered if appropriate. J.D.S. is employed by and has stock in Eli Lilly.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–3 and Table 1 (PDF 460 kb)
Rights and permissions
About this article
Cite this article
Snelgrove, R., Goulding, J., Didierlaurent, A. et al. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol 9, 1074–1083 (2008). https://doi.org/10.1038/ni.1637
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.1637